Back to trial details

Intake questionnaire

Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults

Applying to Vanderbilt Vaccine (VV) CRS Site# 30352 · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 2 answered

1. Are you between 18 and 55 years old?
2. Are you able to travel to Nashville for study visits?